P/E at 65.01 vs Industry's 63.20: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium Amidst Sector Parity

Apollo Hospitals Enterprise Ltd. trades at a P/E of 65.01, slightly above the hospital industry’s average of 63.20. This premium, while not extreme, suggests investors are willing to pay more for the company’s earnings relative to peers. The market capitalisation stands at a substantial ₹1,28,188.34 crores, underscoring its large-cap stature within the hospital sector. The premium valuation may reflect confidence in the company’s earnings quality or growth prospects, but it also raises questions about sustainability given sector-wide pressures. Previously rated Hold, what is Apollo Hospitals’ current rating? The four-parameter analysis factors in the valuation premium alongside performance and technical signals.

Performance Across Timeframes: Strong Long-Term Gains with Consistent Momentum

The stock’s performance over the past year has been robust, delivering a 23.79% gain compared to the Sensex’s 6.73% loss. This outperformance extends over multiple horizons: a 3-month return of 18.63% versus the Sensex’s flat 0.13%, a 1-month gain of 4.93% against the Sensex’s 1.88%, and a year-to-date rise of 26.59% while the benchmark declined 9.71%. Even over longer periods, Apollo Hospitals has delivered impressive returns, with 3-year gains of 71.91%, 5-year returns of 137.73%, and a remarkable 10-year appreciation of 541.57%, all substantially ahead of the Sensex’s respective 17.37%, 45.81%, and 176.63%. This consistent alpha generation highlights the company’s resilience and growth trajectory within the hospital sector. However, the stock’s 1-day and 1-week performances show more modest gains of 0.83% and 0.26%, respectively, while the Sensex declined by 0.80% and 1.71%, indicating short-term relative strength but a more cautious momentum. Is this short-term momentum sustainable or a pause before further gains?

Moving Average Configuration: Bullish Across All Key Averages

Technically, Apollo Hospitals Enterprise Ltd. is trading above all major moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This comprehensive positioning signals a strong uptrend and suggests broad-based buying interest across short, medium, and long-term horizons. The stock is also just 1.11% shy of its 52-week high of ₹8,948.1, reinforcing the strength of its recent rally. Such a configuration typically indicates sustained momentum, but given the premium valuation, investors may want to monitor if this trend continues or if profit-taking emerges near all-time highs. Is this a genuine recovery or a relief rally that will fade at the 50 DMA? The moving average configuration provides the clearest answer.

Sector Context: Hospital Industry Shows Mixed Results

The hospital sector, within which Apollo Hospitals operates, has exhibited a mixed performance landscape recently. While some companies have reported flat or negative returns, how does Apollo’s consistent outperformance affect its relative standing in the sector? The sector’s average P/E of 63.20 reflects moderate valuation levels, and Apollo’s slight premium suggests it is viewed as a leader or a higher-quality operator. The stock’s ability to maintain gains across multiple timeframes while the sector faces headwinds is notable, but it also raises questions about valuation sustainability amid sector-wide challenges such as regulatory pressures and rising costs.

Rating Context: Previously Hold, Now Reassessed

MarketsMOJO had previously rated Apollo Hospitals Enterprise Ltd. as Hold before the rating was updated on 11 May 2026. The reassessment reflects the company’s improved performance metrics and technical strength, alongside its valuation premium. This change invites investors to consider the implications of the updated rating in light of the stock’s strong multi-year returns and current technical positioning. Should investors in Apollo Hospitals hold, buy more, or reconsider? The current rating provides the answer.

Conclusion: Data Reflects Strong Momentum with Valuation Caution

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock with robust long-term performance and a technical setup that supports continued momentum. Its P/E ratio at 65.01, slightly above the industry average, indicates a valuation premium that investors appear willing to pay for quality and growth. The stock’s consistent outperformance versus the Sensex across multiple timeframes, combined with its position above all major moving averages, signals strength. Yet, the premium valuation and proximity to 52-week highs suggest a need for vigilance. Is this premium justified by fundamentals, or is it a signal to reassess exposure? The evolving rating and comprehensive data analysis offer valuable insights for investors navigating this dynamic stock.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →